Requip-Modutab 4 mg prolonged-release tablets

*
Pharmacy Only: Prescription
  • Company:

    GlaxoSmithKline (Ireland) Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Licence number Strength ATC code Dosage form PA1077/037/008 4 milligram(s) N04BC,N04BC04 Prolonged-release tablet